Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
Scientists at the EU4MOFs research network have taken the initiative to standardize the reporting of synthetic procedures and material properties of metal–organic frameworks (MOFs). To this aim, they ...
A critical-analytical portrait of Southeast Asia’s answer to Trump, as the Indonesian President—formerly the Suharto dictatorship’s crown prince and chief butcher in East Timor—re-centralizes power in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results